Prime Minister Mohammed Al-Sudani has launched the construction of Iraq’s largest pharmaceutical city in southern Baghdad, marking a major step toward advancing local medicine production and healthcare self-sufficiency.
The Health City for Pharmaceutical Industries spans 120,000 square metres and will include five major manufacturing facilities with a total investment exceeding USD 500 million. These facilities will focus on the production of biosimilar medicines, plasma derivatives, peritoneal dialysis solutions, medical textiles, and disposable medical supplies, in partnership with leading companies such as Hetero, Accord Healthcare (UK), Prothya Biosolutions (Netherlands), and Vantive (USA).
The project also includes a research and development centre in collaboration with Sartorius (Germany), as well as supporting infrastructure such as medical warehouses and solar-powered electricity stations.
During the ceremony, Prime Minister Al-Sudani inaugurated three peritoneal dialysis centres in Baghdad, Nineveh, and Erbil via videoconference, improving access to essential treatment across Iraq.
In parallel, three memorandums of principles were signed with Accord UK, Abbott (USA), and Sartorius (Germany) to produce biosimilar medicines for cancer and chronic diseases and establish an advanced research centre within the Health City complex.
The government described the initiative as a strategic investment in Iraq’s healthcare sector, designed to localise pharmaceutical manufacturing, create thousands of jobs, and enhance national pharmaceutical security.
- Published: 13th October, 2025
- Location: Baghdad
- Country: Iraq
- Editor: Nour Ghanem
- Category: Investment
